Shandong Sino-Agri United Biotechnology Co.,Ltd.
SZSE:003042.SZ
17.36 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2017 Q2 | 2017 Q1 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 547.857 | 437.773 | 326.299 | 457.188 | 392.571 | 504.847 | 426.861 | 495.071 | 592.467 | 419.025 | 444.776 | 369.242 | 446.189 | 364.866 | 398.638 | 305.156 | 515.552 | 348.84 | 253.006 | 308.294 | 308.294 | 240.15 | 240.15 |
| Cost of Revenue
| 476.855 | 401.136 | 351.392 | 413.052 | 357.581 | 407.578 | 337.989 | 397.258 | 486.22 | 303.942 | 272.495 | 283.932 | 382.63 | 276.431 | 301.312 | 231.294 | 381.441 | 260.457 | 170.655 | 205.787 | 205.787 | 171.381 | 171.381 |
| Gross Profit
| 71.002 | 36.637 | -25.093 | 44.135 | 34.99 | 97.269 | 88.872 | 97.813 | 106.247 | 115.082 | 172.281 | 85.31 | 63.558 | 88.435 | 97.325 | 73.862 | 134.111 | 88.383 | 82.351 | 102.508 | 102.508 | 68.769 | 68.769 |
| Gross Profit Ratio
| 0.13 | 0.084 | -0.077 | 0.097 | 0.089 | 0.193 | 0.208 | 0.198 | 0.179 | 0.275 | 0.387 | 0.231 | 0.142 | 0.242 | 0.244 | 0.242 | 0.26 | 0.253 | 0.325 | 0.332 | 0.332 | 0.286 | 0.286 |
| Reseach & Development Expenses
| 28.61 | 9.537 | 31.304 | 24.439 | 28.653 | 14.088 | 25.554 | 29.981 | 31.775 | 16.601 | 31.87 | 14.486 | 15.202 | 12.075 | 17.643 | 13.562 | 21.516 | 12.088 | 17.764 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| -8.131 | 37.75 | -91.887 | 103.597 | -14.188 | 45.247 | -89.689 | 75.947 | -5.113 | 53.659 | -59.67 | 61.892 | -4.852 | 41.518 | -56.68 | 71.192 | -18.743 | 32.865 | -111.43 | 35.181 | 35.181 | 25.16 | 25.16 |
| Selling & Marketing Expenses
| 12.019 | 11.174 | 18.188 | 19.39 | 15.606 | 7.887 | 9.156 | 14.483 | 12.853 | 8.647 | 14.507 | 10.928 | 12.387 | 7.594 | 9.71 | 8.612 | 11.579 | 8.229 | 24.174 | 12.758 | 12.758 | 10.555 | 10.555 |
| SG&A
| 38.282 | 47.93 | -73.698 | 122.986 | 1.418 | 53.134 | -80.534 | 90.43 | 7.74 | 62.306 | -45.163 | 72.82 | 7.535 | 49.112 | -46.97 | 79.804 | -7.164 | 41.095 | -87.256 | 47.939 | 47.939 | 35.715 | 35.715 |
| Other Expenses
| -2.825 | -0.158 | 0.288 | 1.214 | -1.057 | -0.544 | 118.068 | -35.805 | 38.046 | 1.669 | -0.167 | 0.287 | -0.038 | -0.115 | -0.023 | 0.015 | -0.985 | 0.431 | -0.104 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 69.717 | 57.625 | 93.022 | 109.614 | 69.724 | 66.678 | 63.088 | 84.606 | 77.562 | 80.575 | 98.531 | 56.927 | 52.994 | 62.103 | 60.774 | 45.626 | 63.232 | 53.655 | 73.141 | 58.361 | 58.361 | 45.957 | 45.957 |
| Operating Income
| 1.286 | -20.988 | -136.288 | -84.583 | -38.039 | 21.673 | 10.573 | 11.379 | 37.616 | 40.93 | 59.896 | 23.796 | 3.281 | 21.962 | 23.314 | 5.7 | 69.22 | 21.17 | 3.817 | 53.054 | 53.054 | 32.781 | 32.781 |
| Operating Income Ratio
| 0.002 | -0.048 | -0.418 | -0.185 | -0.097 | 0.043 | 0.025 | 0.023 | 0.063 | 0.098 | 0.135 | 0.064 | 0.007 | 0.06 | 0.058 | 0.019 | 0.134 | 0.061 | 0.015 | 0.172 | 0.172 | 0.137 | 0.137 |
| Total Other Income Expenses Net
| -4.373 | -5.204 | 0.288 | -0.049 | 0.206 | 0.196 | 0.227 | -0.156 | -16.689 | -12.847 | -0.167 | -4.373 | -7.248 | -4.484 | -13.261 | -22.52 | -2.644 | -13.127 | -5.498 | -8.908 | -8.908 | -9.968 | -9.968 |
| Income Before Tax
| -3.087 | -26.192 | -135.999 | -84.631 | -37.833 | 21.869 | 10.8 | 11.224 | 20.926 | 28.083 | 59.729 | 24.009 | 3.316 | 21.848 | 23.291 | 5.715 | 68.236 | 21.601 | 3.713 | 44.147 | 44.147 | 22.812 | 22.812 |
| Income Before Tax Ratio
| -0.006 | -0.06 | -0.417 | -0.185 | -0.096 | 0.043 | 0.025 | 0.023 | 0.035 | 0.067 | 0.134 | 0.065 | 0.007 | 0.06 | 0.058 | 0.019 | 0.132 | 0.062 | 0.015 | 0.143 | 0.143 | 0.095 | 0.095 |
| Income Tax Expense
| 7.955 | -4.656 | -29.146 | -10.853 | -8.973 | 4.848 | -7.16 | -2.446 | 3.352 | 4.149 | 7.461 | 0.057 | -0.75 | 3.538 | 0.909 | 0.946 | 10.654 | 2.808 | -8.862 | 6.597 | 6.597 | 3.149 | 3.149 |
| Net Income
| -11.042 | -21.535 | -106.853 | -73.778 | -28.86 | 17.021 | 17.96 | 13.669 | 17.575 | 23.934 | 52.268 | 23.952 | 4.066 | 18.31 | 22.381 | 4.77 | 57.582 | 18.793 | 12.574 | 37.549 | 37.549 | 19.663 | 19.663 |
| Net Income Ratio
| -0.02 | -0.049 | -0.327 | -0.161 | -0.074 | 0.034 | 0.042 | 0.028 | 0.03 | 0.057 | 0.118 | 0.065 | 0.009 | 0.05 | 0.056 | 0.016 | 0.112 | 0.054 | 0.05 | 0.122 | 0.122 | 0.082 | 0.082 |
| EPS
| -0.078 | -0.15 | -0.75 | -0.52 | -0.2 | 0.12 | 0.13 | 0.13 | 0.16 | 0.17 | 0.37 | 0.29 | 0.049 | 0.17 | 0.27 | 0.057 | 0.7 | 0.18 | 0.15 | 0.52 | 0.52 | 0.29 | 0.29 |
| EPS Diluted
| -0.078 | -0.15 | -0.75 | -0.52 | -0.2 | 0.12 | 0.13 | 0.13 | 0.16 | 0.17 | 0.37 | 0.29 | 0.049 | 0.17 | 0.27 | 0.057 | 0.7 | 0.18 | 0.15 | 0.52 | 0.52 | 0.29 | 0.29 |
| EBITDA
| 44.808 | -17.322 | -116.601 | -66.228 | -25.675 | 27.613 | 23.542 | 16.23 | 31.716 | 35.306 | 73.972 | 28.893 | 9.38 | 27.221 | 28.958 | 21.068 | 70.606 | 35.598 | 9.691 | 71.101 | 71.101 | 47.812 | 47.812 |
| EBITDA Ratio
| 0.082 | -0.04 | -0.357 | -0.145 | -0.065 | 0.055 | 0.055 | 0.033 | 0.054 | 0.084 | 0.166 | 0.078 | 0.021 | 0.075 | 0.073 | 0.069 | 0.137 | 0.102 | 0.038 | 0.231 | 0.231 | 0.199 | 0.199 |